Clinical Trials for Temodar

3 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
TreatmentVICCGI1250
04/09/2013
A Phase I/II Study of the Combination of Temozolomide and Pazopanib in Advanced Pancreatic Neuroendocrine Tumors (PNET)
TreatmentVICCNEU1216
10/02/2012
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF with Adjuvant Temozolomide in Patients with Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
TreatmentCOGACNS0821
10/08/2011
ACNS0821 - Temozolomide with Irinotecan versus Temozolomide, Irinotecan plus Bevacizumab (NSC# 704865, BB-IND# 7921) for Recurrent/Refractory Medulloblastoma/CNS PNET of Childhood, A COG Randomized Phase II Screening Trial

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.